共 300 条
[1]
Polanco JC(2018)Amyloid-β and tau complexity-towards improved biomarkers and targeted therapies Nat Rev Neurol 14 22-39
[2]
Li C(2018)Trial of solanezumab for mild dementia due to Alzheimer’s disease N Engl J Med 378 321-330
[3]
Bodea LG(2018)Randomized trial of Verubecestat for mild-to-moderate Alzheimer’s disease N Engl J Med 378 1691-1703
[4]
Martinez-Marmol R(2015)Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases Nat Rev Neurol 11 41-55
[5]
Meunier FA(2015)Amyloid biomarkers in Alzheimer’s disease Trends Pharmacol Sci 36 297-309
[6]
Götz J(2015)Tau in bliofluids - relation to pathology, imaging and clinical features Neuropathol Appl Neurobiol 43 194-199
[7]
Honig LS(2013)Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 207-216
[8]
Vellas B(2018)Biomarkers for Alzheimer disease: classical and novel candidate’s review Neuroscience 370 181-190
[9]
Woodward M(2017)Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers Lancet Neurol 16 661-676
[10]
Boada M(2017)Synaptic impairment in Alzheimer’s disease: a dysregulated symphony Trends Neurosci 40 347-357